Contact: Katie Glenn, kglenn@acc.org, 202-375-6472 WASHINGTON (Dec 19, 2019) – American College of Cardiology President Richard J. Kovacs, MD, FACC, made the following statement on the inclusion of a Tobacco 21 provision in the Fiscal Year 2020 Domestic Priorities and International Assistance appropriations minibus (H.R. 1865) legislation…
AI outperformed clinicians and almost matched hs-TnT testing, but one expert questioned if this is where it’s needed most.
Latest analysis of the HELIOS-B trial finds vutrisiran significantly lowers mortality and cardiovascular events in patients with ATTR-CM.
As in the SMART trial, early hemodynamic differences have yet to result in a clinical impact—but it may just be a matter of time.
Each valve was associated with certain benefits, but one-year outcomes were largely similar.
Each valve was associated with certain benefits, but one-year outcomes were largely similar.
Recent developments of interest in cardiovascular medicine
Eating small amounts of processed foods daily may increase the risk of hypertension, heart disease, cancer, digestive disorders, and early death, according to a new…
Rapidly rising rates of heart disease across Southeast Asia, East Asia and Oceania are being driven by localized consequences of industrialization and rapid economic growth,…
Contact: Katie Glenn, kglenn@acc.org , The American College of Cardiology has recognized three outstanding abstract presentations as Abstract Award winners at the ACC Asia 2025…
Contact: Julie Boyland, Jboyland@acc.org, The American College of Cardiology (ACC) recognized more than 40 individuals from throughout the Asia-Pacific region who have earned the distinguished…
